SecBot SecBot
425 ·Filed Aug 11, 2026

PLNH

Planet 13 Holdings Inc.
NEUTRAL
Impact 5/10
Horizonweeks Processed3mo ago SEC0001104659-26-093727
Rule 425 M&A communications
Actionable Insight • Neutral

Monitor Vireo's stock price (VREOF) as it directly determines the value of the merger consideration for Planet 13 shareholders. The earnings beat may provide near-term support for Vireo shares, but the deal remains subject to regulatory and shareholder approvals.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$0.1300
T+0 close · Aug 11, 2026 · via day close
Latest settled
−39.69%
T+60 · $0.0784
Vs SPY
−39.55%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 11 $0.1300entry
  2. T+1 · 3mo ago +5.38%α +5.13% · $0.1370
  3. T+5 · 3mo ago +13.08%α +13.48% · $0.1470
  4. T+20 · 2mo ago +7.69%α +8.75% · $0.1400
  5. T+60 · 13d ago −39.69%α −39.55% · $0.0784

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vireo Growth Inc. reported Q2 2026 revenue of $209.3M (+335% YoY) and Adjusted EBITDA of $41.5M, driven by recent M&A. The filing also reiterates the pending all-stock merger with Planet 13, which will create the largest U.S. cannabis operator by dispensary count. For Planet 13 shareholders, Vireo's strong financial performance supports the deal's value proposition.

Key Financial Metrics

Deal Type
merger

Key Facts

  • Vireo Q2 GAAP revenue $209.3M, up 335% YoY from $48.1M
  • Vireo Q2 Adjusted EBITDA $41.5M vs $13.3M YoY
  • Vireo closed Q2 with $122.7M cash
  • Planet 13 merger announced post-quarter: all-stock, 0.015383618 Vireo shares per PLNH share
  • Vireo expects to become largest U.S. cannabis operator by dispensary count with ~270 dispensaries

Financial Impact

Vireo's Q2 revenue of $209.3M and Adjusted EBITDA of $41.5M demonstrate strong operational scale, supporting the combined entity's financial profile post-merger.

revenueadjusted_ebitdacash

Risk Factors

  • Regulatory approvals for the merger may be delayed or denied
  • Integration risks from Vireo's multiple concurrent acquisitions
  • Cannabis industry regulatory uncertainty at federal level

Market Snapshot

Exchange
OTC
Sector
Agricultural Production-Crops
Analyst Consensus
9% bullish (11 analysts)

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001104659-26-093727
Document: vreof-20251112x425.htm0001104659-26-093727
Document: 0001104659-26-093727-index-headers.html0001104659-26-093727
Document: 0001104659-26-093727-index.html0001104659-26-093727
Document: 0001104659-26-093727.txt0001104659-26-093727

US Market Status

Market Closed · Opens in 5h 47m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 11, 2026